Companies /Healthcare

So-Young International Inc

NASDAQ: SY Health Information Services
$2.75
▼ $0.04 (−1.26%) today
Markets open · 11:25am ET

Q3 2025 Earnings

Reported Nov 16, 2025, 7:00pm ET · SEC source
$-0.12
Beat +63.87%
EPS · est. $-0.33
$54.3M
Miss −85.95%
Revenue · est. $386.6M
−17.7%
Trailing market
SY vs S&P since report
5 quarters
Consecutive EPS beats

Market Reaction

−8.45%
Day of report
+3.87%
Next session
−6.55%
One week
−16.07%
30 days

S&P 500 over the same 30 days: +1.62%.

Did SY Beat Earnings? Q3 2025 Results

Revenue was $54.32 million, below the $398.24 million consensus estimate. The company reported a non-GAAP net loss of $8.66 million, compared to a non-GAAP net income of $22.25 million in the same period last year. Total revenues increased by 4.0% year-over-year, driven by a significant rise in aesthetic treatment services, which surged 304.6% to $25.79 million. However, information and reservation services revenues declined by 34.5% to $16.47 million. The number of verified treatment visits increased significantly, reflecting strong operational performance. Despite the revenue growth, the company faced increased costs and operating expenses, leading to a net loss. The CEO emphasized the company's focus on expanding its network of aesthetic centers and improving operational efficiency.

Key Takeaways
  • Business expansion of branded aesthetic centers

“In the third quarter, our branded aesthetic centers continued to deliver strong, high-quality growth with aesthetic treatment services revenues once again exceeding our guidance range.”

So-Young International CEO, on the earnings call

Forward Guidance & Outlook

For Q4 2025, So-Young expects aesthetic treatment services revenues to be between $30.3 million and $31.7 million, representing a significant increase from the same period in 2024. The company plans to continue expanding its network of aesthetic centers and improving operational efficiency.

SY YoY Financials

Q3 2025 vs Q3 2024 · SEC filings Q3 2024 Q3 2025
$0$200.0M$400.0M$371.8M$54.3MRevenue$229.6M$25.7MGross Profit
$0$200.0M$400.0MRevenueGross Profit

SY Revenue by Segment

Aesthetic Treatment Services
Information and Reservation Services
Sales of Medical Products and Maintenance Services
Other Services

Figures from SEC filings and company reports. Not investment advice.